Megazol

Megazol
Clinical data
ATC code	None;
Identifiers
	IUPAC name 5-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazol-2-amine;
CAS Number	19622-55-0 ;
ChemSpider	27598;
UNII	VQ8UH664ZJ;
CompTox Dashboard (EPA)	DTXSID50173298 ;
Chemical and physical data
Formula	C6H6N6O2S
Molar mass	226.21 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cn1c(cnc1c2nnc(s2)N)[N+](=O)[O-];

Megazol (CL 64855) is a nitroimidazole based drug that cures some protozoan infections.

A study of nitroimidazoles found the drug extremely effective against T. cruzi and T. brucei which cause Chagas disease and African sleeping sickness, respectively. The drug is considerably more effective than standard benznidazole therapy (for Chagas) which is considered the gold standard.^[1] This is despite that other nitroimidazoles proved ineffective against these pathogens.^{[citation needed]}

References

^ Hall BS, Wilkinson SR (January 2012). "Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation". Antimicrobial Agents and Chemotherapy. 56 (1): 115–23. doi:10.1128/AAC.05135-11. PMC 3256028. PMID 22037852.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

[1] Hall BS, Wilkinson SR (January 2012). "Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation". Antimicrobial Agents and Chemotherapy. 56 (1): 115–23. doi:10.1128/AAC.05135-11. PMC 3256028. PMID 22037852.

[1]